Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Benzylpenicilloyl G Polylysine
Therapeutic Area : Immunology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of Skin Testing Reagents for Penicillin Allergy
Details : Benzylpenicilloyl Polylysine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Drug Hypersensitivity.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
March 26, 2013
Lead Product(s) : Benzylpenicilloyl G Polylysine
Therapeutic Area : Immunology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable